Abstract:Trigeminal ganglion (TG) is the first station of sensory pathways in the orofacial region. The TG neurons communicate with satellite glial cells (SGCs), macrophages and other cells forming a functional unit that is responsible for processing of orofacial sensory information. Purinergic signaling, one of the most widespread autocrine and paracrine pathways, plays a crucial role in intercellular communication. The multidirectional action of purinergic signaling in different cell types contributes to the neuromod… Show more
“…Among them, 61 candidate proteins were then filtered for being a bona fide secreted factor, i.e., possessing a signal peptide, 11 of which have the specific receptor(s) documented (Supplementary information, Table S1 ). We further analyzed the expression of these receptors in the published single-cell RNA-seq (scRNA-seq) dataset of mouse trigeminal ganglionic neurons (GSE213105), 25 whose axonal projections control Me5-L/-R and 5N-L/-R, the signature regions activated by multiple cancer types. Through this multi-omic screening, three candidate proteins (LIF, pigment epithelium-derived factor, and thrombospondin-1) were obtained for in-depth functional examination (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…We note that the detailed mechanisms by which LIF and Gal3 induce brain responses warrant more in-depth investigations. Notably, in the multi-omic screening of cancer cell-derived signaling molecules, we analyzed the expression of the putative receptor(s) for each candidate in the published scRNA-seq dataset of mouse trigeminal ganglionic neurons, 25 whose axonal projections control Me5-L/-R and 5N-L/-R, the signature regions activated by multiple peripheral tumors. This scRNA-seq analysis revealed that the LIF receptor ( Lifr ) is highly expressed in those neuronal populations (Fig.…”
Neural signals can significantly influence cancer prognosis. However, how cancer cells may proactively modulate the nervous system to benefit their own survival is incompletely understood. In this study, we report an overlapping pattern of brain responses, including that in the paraventricular nucleus of the hypothalamus, in multiple mouse models of peripheral cancers. A multi-omic screening then identifies leukemia inhibitory factor (LIF) and galectin-3 (Gal3) as the key cytokines released by these cancer cell types to trigger brain activation. Importantly, increased plasma levels of these two cytokines are observed in patients with different cancers. We further demonstrate that pharmacologic or genetic blockage of cancer cell-derived LIF or Gal3 signaling abolishes the brain responses and strongly inhibits tumor growth. In addition, ablation of peripheral sympathetic actions can similarly restore antitumor immunity. These results have elucidated a novel, shared mechanism of multiple cancer cell types hijacking the nervous system to promote tumor progression.
“…Among them, 61 candidate proteins were then filtered for being a bona fide secreted factor, i.e., possessing a signal peptide, 11 of which have the specific receptor(s) documented (Supplementary information, Table S1 ). We further analyzed the expression of these receptors in the published single-cell RNA-seq (scRNA-seq) dataset of mouse trigeminal ganglionic neurons (GSE213105), 25 whose axonal projections control Me5-L/-R and 5N-L/-R, the signature regions activated by multiple cancer types. Through this multi-omic screening, three candidate proteins (LIF, pigment epithelium-derived factor, and thrombospondin-1) were obtained for in-depth functional examination (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…We note that the detailed mechanisms by which LIF and Gal3 induce brain responses warrant more in-depth investigations. Notably, in the multi-omic screening of cancer cell-derived signaling molecules, we analyzed the expression of the putative receptor(s) for each candidate in the published scRNA-seq dataset of mouse trigeminal ganglionic neurons, 25 whose axonal projections control Me5-L/-R and 5N-L/-R, the signature regions activated by multiple peripheral tumors. This scRNA-seq analysis revealed that the LIF receptor ( Lifr ) is highly expressed in those neuronal populations (Fig.…”
Neural signals can significantly influence cancer prognosis. However, how cancer cells may proactively modulate the nervous system to benefit their own survival is incompletely understood. In this study, we report an overlapping pattern of brain responses, including that in the paraventricular nucleus of the hypothalamus, in multiple mouse models of peripheral cancers. A multi-omic screening then identifies leukemia inhibitory factor (LIF) and galectin-3 (Gal3) as the key cytokines released by these cancer cell types to trigger brain activation. Importantly, increased plasma levels of these two cytokines are observed in patients with different cancers. We further demonstrate that pharmacologic or genetic blockage of cancer cell-derived LIF or Gal3 signaling abolishes the brain responses and strongly inhibits tumor growth. In addition, ablation of peripheral sympathetic actions can similarly restore antitumor immunity. These results have elucidated a novel, shared mechanism of multiple cancer cell types hijacking the nervous system to promote tumor progression.
“…The ABCB10 transporter is also downregulated by NMN exposure. ABCB10 has been shown to be highly expressed in neurons, and it has been suggested to play a role in the regulation of mitochondrial function in these cells [ 63 ]. It has been implicated in the response to oxidative stress, which is a common feature of many neurological disorders [ 64 ].…”
Nicotinamide mononucleotide (NMN) has emerged as a promising therapeutic intervention for age-related disorders, including type 2 diabetes. In this study, we confirmed the previously observed effects of NMN treatment on glucose uptake and investigated its underlying mechanisms in various tissues and cell lines. Through the most comprehensive proteomic analysis to date, we discovered a series of novel organ-specific effects responsible for glucose uptake as measured by the IPGTT: adipose tissue growing (suggested by increased protein synthesis and degradation and mTOR proliferation signaling upregulation). Notably, we observed the upregulation of thermogenic UCP1, promoting enhanced glucose conversion to heat in intermuscular adipose tissue while showing a surprising repressive effect on mitochondrial biogenesis in muscle and the brain. Additionally, liver and muscle cells displayed a unique response, characterized by spliceosome downregulation and concurrent upregulation of chaperones, proteasomes, and ribosomes, leading to mildly impaired and energy-inefficient protein synthesis machinery. Furthermore, our findings revealed remarkable metabolic rewiring in the brain. This involved increased production of ketone bodies, downregulation of mitochondrial OXPHOS and TCA cycle components, as well as the induction of well-known fasting-associated effects. Collectively, our data elucidate the multifaceted nature of NMN action, highlighting its organ-specific effects and their role in improving glucose uptake. These findings deepen our understanding of NMN’s therapeutic potential and pave the way for novel strategies in managing metabolic disorders.
“…Current studies disagree about whether Panx1 upregulation primarily occurs in sensory neurons or their satellite cells, with one study finding expression mainly in neurons following SNI surgery in rats [ 126 ], and another finding that deletion of Panx1 in GFAP-expressing cells greatly reduced the pain response in a murine model of orofacial inflammatory pain [ 123 ]. Under homeostatic conditions, single-cell RNAseq identified higher and more widespread Panx1 expression in TG neurons than in supporting glia [ 127 ]. Astrocytes also express Panx1, which plays a critical role in ATP signaling, can bind to P2X7, and can potentiate the release of IL-1β [ 128 , 129 , 130 ].…”
Section: Sgcs and Astrocytes In Neuropathic Painmentioning
Preclinical studies have identified glial cells as pivotal players in the genesis and maintenance of neuropathic pain after nerve injury associated with diabetes, chemotherapy, major surgeries, and virus infections. Satellite glial cells (SGCs) in the dorsal root and trigeminal ganglia of the peripheral nervous system (PNS) and astrocytes in the central nervous system (CNS) express similar molecular markers and are protective under physiological conditions. They also serve similar functions in the genesis and maintenance of neuropathic pain, downregulating some of their homeostatic functions and driving pro-inflammatory neuro-glial interactions in the PNS and CNS, i.e., “gliopathy”. However, the role of SGCs in neuropathic pain is not simply as “peripheral astrocytes”. We delineate how these peripheral and central glia participate in neuropathic pain by producing different mediators, engaging different parts of neurons, and becoming active at different stages following nerve injury. Finally, we highlight the recent findings that SGCs are enriched with proteins related to fatty acid metabolism and signaling such as Apo-E, FABP7, and LPAR1. Targeting SGCs and astrocytes may lead to novel therapeutics for the treatment of neuropathic pain.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.